HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is focused on the standardized extraction of psychedelic compounds for the creation of active pharmaceutical ingredients (APIs), the development of natural health products, and therapies to support brain health and enhance the capabilities of the mind. It operates through two divisions: HAVN Labs and HAVN Retail. The HAVN Labs division is engaged in the development of research protocols to cover the production of Psilocybe spp. The Company's HAVN Retail division is focused on formulating and selling natural health products (NHPs) using compounds. It has product licenses, which are focused on four categories of human health and performance: immunity support, cognitive support, stress prevention, and energy support. It offers a range of quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.